Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity

References

• Pisani B, Taylor DO, Mason JW. Inflammatory myocardial diseases and cardiomyopathies. Am J Med 1997; 102: 459–469
   PubMed Web of Science ®Google Scholar
• Caforio AL, McKenna WJ. Recognition and optimum management of myocarditis. Drugs 1996; 52: 515–525
   PubMed Web of Science ®Google Scholar
• Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388–1398
   PubMed Web of Science ®Google Scholar
• Anandasabapathy S, Frishman WH. Innovative drug treatments for viral and autoimmune myocarditis. J Clin Pharmacol 1998; 38: 295–308
   PubMed Web of Science ®Google Scholar
• Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 1993; 22: 1378–1384
   PubMed Web of Science ®Google Scholar
• Konstadoulakis MM, Kroumbouzou H, Tsiamis E, Trikas A, Toutouzas P. Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy. J Clin Lab Immunol 1993; 40: 61–67
   PubMedGoogle Scholar
• Goldman JH, Keeling PJ, Warraich RS, Baig MK, Redwood SR, Dalla Libera L, Sanderson JE, Caforio AL, McKenna WJ. Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 1995; 74: 598–603
   PubMedGoogle Scholar
• Maisch B, Maisch S, Kochsiek K. Immune reactions in tuberculous and chronic constrictive pericarditis. Am J Cardiol 1982; 50: 1007–1013
   PubMed Web of Science ®Google Scholar
• Aberer E, Brunner C, Suchanek G, Klade H, Barbour A, Stanek G, Lassmann H. Molecular mimicry and Lyme borreliosis: A shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol 1989; 26: 732–737
   PubMed Web of Science ®Google Scholar
• Kaplan MH, Frengley JD. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol 1969; 24: 459–473
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J. Autoimmunity in Chagas' disease: Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T-cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996; 98: 1709–1712
   PubMed Web of Science ®Google Scholar
• Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990; 16: 839–846
   PubMedGoogle Scholar
• Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PM, Assis RV, Pedra F, Neumann J, Goldberg A, Patarroyo ME, Pilleggi F, Kalil J. Human heart-infiltrating t-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995; 92: 415–420
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Kalil J. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 2001; 34: 187–192
   PubMed Web of Science ®Google Scholar
• Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139: 3630–3636
   PubMed Web of Science ®Google Scholar
• Pummerer C, Berger P, Fruhwirth M, Ofner C, Neu N. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab Invest 1991; 65: 538–547
   PubMed Web of Science ®Google Scholar
• Neu N, Ploier B, Ofner C. Cardiac myosin-induced myocarditis: Heart autoantibodies are not involved in the induction of the disease. J Immunol 1990; 145: 4094–4100
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Cardiac myosin and the Th1/Th2 paradigm in autoimmune myocarditis. Am J Pathol 2001; 159: 5–12
   PubMed Web of Science ®Google Scholar
• Fuse K, Kodama M, Ito M, Okura Y, Kato K, Hanawa H, Aoki S, Aizawa Y. Polarity of helper T-cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats. Clin Exp Immunol 2003; 134: 403–408
   PubMed Web of Science ®Google Scholar
• Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001; 104: 3145–3151
   PubMed Web of Science ®Google Scholar
• Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 2001; 159: 193–203
   PubMed Web of Science ®Google Scholar
• Smith SC, Allen PM. Myosin-induced acute myocarditis is a T-cell-mediated disease. J Immunol 1991; 147: 2141–2147
   PubMed Web of Science ®Google Scholar
• Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 2006; 203: 2009–2019
   PubMed Web of Science ®Google Scholar
• Shiverick KT, Thomas LL, Alpert NR. Purification of cardiac myosin: Application to hypertrophied myocardium. Biochim Biophys Acta 1975; 393: 124–133
   PubMedGoogle Scholar
• Leon JS, Daniels MD, Toriello KM, Wang K, Engman DM. A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun 2004; 72: 3410–3417
   PubMed Web of Science ®Google Scholar
• Leon JS, Wang K, Engman DM. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 2003; 107: 2264–2269
   PubMed Web of Science ®Google Scholar
• Leon JS, Wang K, Engman DM. Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas disease. J Immunol 2003; 171: 4271–4277
   PubMed Web of Science ®Google Scholar
• Godsel LM, Leon JS, Wang K, Fornek JL, Molteni A, Engman DM. Captopril prevents experimental autoimmune myocarditis. J Immunol 2003; 171: 346–352
   PubMed Web of Science ®Google Scholar
• Godsel LM, Wang K, Schodin BA, Leon JS, Miller SD, Engman DM. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation 2001; 103: 1709–1714
   PubMed Web of Science ®Google Scholar
• Minoprio P, el Cheikh MC, Murphy E, Hontebeyrie-Joskowicz M, Coffman R, Coutinho A, O'Garra A. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol 1993; 151: 4200–4208
   PubMed Web of Science ®Google Scholar
• Donermeyer DL, Beisel KW, Allen PM, Smith SC. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med 1995; 182: 1291–1300
   PubMed Web of Science ®Google Scholar
• Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2002; 2: 85–95
   PubMed Web of Science ®Google Scholar
• Lawson CM. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 2000; 57: 552–560
   PubMedGoogle Scholar
• Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun 2001; 16: 175–186
   PubMed Web of Science ®Google Scholar
• Afanasyeva M, Hill SL, Kaya Z, Rose NR, Wang Y. Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. J Am Coll Cardiol 2000; 36: 1992–1999
   PubMed Web of Science ®Google Scholar
• Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995; 181: 1123–1131
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Tsukada Y, Miyakoshi A, Sakuma H, Kohyama K. C protein-induced myocarditis and subsequent dilated cardiomyopathy: Rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy. J Immunol 2004; 173: 3535–3541
   PubMed Web of Science ®Google Scholar
• Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol 2000; 164: 670–678
   PubMed Web of Science ®Google Scholar
• Maier R, Miller S, Kurrer M, Krebs P, de Giuli R, Kremer M, Scandella E, Ludewig B. Quantification and characterization of myosin peptide-specific CD4+T cells in autoimmune myocarditis. J Immunol Methods 2005; 304: 117–125
   PubMed Web of Science ®Google Scholar
• Rohn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 2006; 2857–2867
   PubMed Web of Science ®Google Scholar
• Dal Canto MC, Melvold RW, Kim BS, Miller SD. Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 1995; 32: 215–229
   PubMed Web of Science ®Google Scholar
• Ley K, Smith E, Stark MA. IL-17a-producing neutrophil-regulatory T lymphocytes. Immunol Res 2006; 34: 229–242
   PubMed Web of Science ®Google Scholar
• Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006; 177: 1416–1420
   PubMed Web of Science ®Google Scholar